Raymond James Financial Services Advisors, Inc. Neoleukin Therapeutics, Inc. Call Options Transaction History
Raymond James Financial Services Advisors, Inc.
- $73.5 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NLTX
# of Institutions
1Shares Held
199KCall Options Held
0Put Options Held
0About Neoleukin Therapeutics, Inc.
- Ticker NLTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 42,579,900
- Description
- Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of vario...